Schema-Root.org logo

 

  cross-referenced news and research resources about

 Johnson & Johnson subsidiary Janssen

Schema-Root.org logo
images:  google   yahoo YouTube
spacer

updated Mon. October 14, 2019

-
Johnson & Johnson's Janssen Pharmaceuticals unit – which manufactures drugs including the opioid Duragesic, a form of fentanyl – called its marketing activities “appropriate and responsible.” Endo did not respond to a request for comment. Prescription opioids are intended to treat pain, but the outbreak ...
Dominic Caruso, Johnson & Johnson's longest-serving CFO in the company's 132-year history, will retire in September. He came to J&J in 1999 through the ... will replace Caruso on July 1. Wolk has been with J&J for 19 years and was once CFO of the Janssen Pharmaceutical Companies. Release ...

Mr Wolk has been with Johnson & Johnson for 19 years and has served on the finance leadership team, reporting directly to Mr Caruso since 2014. Previously, he was VP, finance and CFO of the Janssen Pharmaceutical Companies of Johnson & Johnson and was a member of the Janssen Group ...
Wolk has worked with Johnson & Johnson for 19 years, and has directly served under Caruso since 2014. Prior to joining J&J, Wolk acted as CFO of J&J's Janssen Pharmaceutical companies and was a member of Janssen's group operating committee. “Joe is a strong, collaborative, credo-based leader ...
Mr. Wolk has been with Johnson & Johnson for 19 years and has served on the Finance Leadership team, reporting directly to Mr. Caruso since 2014. Previously, he was Vice President, Finance and CFO of the Janssen Pharmaceutical Companies of Johnson & Johnson and was a member of the Janssen ...
Janssen Pharmaceutica, which is part of US healthcare giant Johnson & Johnson (NYSE: JNJ), plans to increase production of its Sirturo (bedaquiline) –an anti-tuberculosis drug – in Russia, at the capacities of a local drugmaker Pharmstandard, according to recent statements of the companies, reportsThe ...

A new analysis from the CANVAS study showed patients with type 2 diabetes (T2D) treated with Johnson & Johnson (JNJ -0.6%) unit Janssen Pharmaceuticals' INVOKANA (canagliflozin) experienced significantly less risk of cardiovascular (CV) death or hospitalization for heart failure (HHF). The data were ...
Biocartis has struck a deal with Johnson & Johnson to expand its presence in the U.S. J&J's Janssen is transferring a respiratory assay panel and some of the staff who worked on it to Biocartis, while also making space available for the company at its site in Raritan, New Jersey. Mechelen, Belgium-based ...
Johnson & Johnson Innovation, the Janssen Pharmaceutical Companies of Johnson & Johnson and A*STAR initiated the World Without Disease Grant Call to support life science innovation in Singapore and advance the discovery and development of solutions to prevent, intercept and cure diseases.
The next-gen biologic from Johnson & Johnson's Janssen began airing its first DTC campaign two weeks ago, joining two other new-age drugs already tearing up the psoriasis market and grabbing TV time. Both Novartis' Cosentyx and Eli Lilly's Taltz have spent big on TV to establish their brands. Novartis ...
Johnson & Johnson Innovation, the Janssen Pharmaceutical Companies of Johnson & Johnson and A*STAR initiated the World Without Disease Grant Call to support life science innovation in Singapore and advance the discovery and development of solutions to prevent, intercept and cure diseases.
Sierra Oncology and Janssen Sign Supply Agreement for Prostate Cancer Study. Paul Quintaro , Benzinga Staff Writer {{following ? "Following" : "Follow"}}. February 27, 2018 7:42am Comments. Share: ...
Just after New Year's, in an announcement that was easy to overlook in the post-holiday haze, Johnson & Johnson's Janssen Pharmaceutical celebrated an historic FDA approval. The agency cleared new label language for the company's 9-year-old schizophrenia treatment, Invega Sustenna, stating that ...
The U.S. Food and Drug Administration today approved Erleada (apalutamide) for the treatment of patients with prostate cancer that has not spread (non-metastatic), but that continues to grow despite treatment with hormone therapy (castration-resistant). This is the first FDA-approved treatment for ...
Theravance Biopharma Inc. (NASDAQ: TBPH) said Wednesday that Johnson & Johnson's (NYSE: JNJ) Janssen Biotech group will pay $200 million when mid-stage work across two studies in ulcerative colitis and Crohn's disease are completed and another $700 million in development and commercial ...
The lawsuit names Purdue Pharma, Teva Pharmaceutical Industries, Cephalon, Inc., Janssen Pharmaceuticals, Ortho-McNeil-Janssen Pharmaceuticals, Noramco, Inc., Johnson & Johnson, Mallinckrodt LLC, Endo Health Solutions, Allergan, Actavis, Watson Pharmaceuticals, McKesson Corporation, ...
Other companies named in the complaint include Teva, Cephalon, Johnson & Johnson and Janssen. Law firm Simmons Hanly Conroy is handling the lawsuit. The firm is also representing 18 Connecticut cities and towns — including Bridgeport, Fairfield and Newtown — that filed a similar complaint earlier ...

Johnson & Johnson's patent on its top-selling arthritis drug Remicade is invalid, a U.S. appeals court ruled Tuesday in a defeat to the drugmaker that just ... The loss before the nation's top patent court came a week after J&J's Janssen Biotech unit got hit with an invalidity ruling on another blockbuster, the ...
Johnson & Johnson's patent on its top-selling arthritis drug Remicade is invalid, a U.S. appeals court ruled Tuesday in a defeat to the drugmaker that just ... another patent on Remicade that it's using in litigation, though that's been held up for years because of a dispute over whether Janssen had the legal ...
Similar to others filed nationally, Methuen's lawsuit names several well-known companies including Purdue Pharma, Teva Pharmaceutical Industries, Cephalon Inc., Johnson & Johnson and Janssen Pharmaceuticals Inc. It also names AmerisourceBergen Drug Corporation, Cardinal Health Inc., and ...
TITUSVILLE, NJ, January 16, 2018 - The Janssen Pharmaceutical Companies of Johnson & Johnson today announced findings from the U.S. Food and Drug Administration's (FDA) Mini-Sentinel assessment, confirming the positive safety and efficacy profile of XARELTO® (rivaroxaban) established in the ...
The defendants in the case are Purdue Pharma L.P.; Purdue Pharma, Inc.; The Purdue Frederick Company, Inc.; Teva Pharmaceuticals USA, Inc.; Cephalon, Inc.; Johnson & Johnson; Janssen Pharmaceuticals, Inc.; Ortho-McNeil-Janssen Pharmaceuticals, Inc.; Janssen Pharmaceuticals, Inc.; Endo Health ...
Dr Leisha Daly, Country Director of Janssen Ireland, the pharmaceutical company of Johnson & Johnson, and Chair of the J&J Campus Ireland Group, stresses the importance of bringing people together to meet the vision of a world-renowned company. In business it's very important to understand the ...
Results from the Phase 3 CLARITY study demonstrated the superiority of Novartis' (NYSE:NVS) Cosentyx (secukinumab) compared to Johnson & Johnson (NYSE:JNJ) unit Janssen Biotech's Stelara (ustekinumab) in adults with moderate-to-severe plaque psoriasis. At week 12, 66.5% of the Cosentyx ...
The partnership leverages the university's adeno-associated viruses and J&J's anti-Alzheimer's antibodies in hopes to penetrate the blood brain barrier. The partnership involves the pharma giant's innovation-focused arm Johnson & Johnson Innovation and Janssen Pharmaceuticals. J&J hopes to use the ...
Johnson & Johnson has formed an Alzheimer's gene therapy research pact with the University of Pennsylvania. The partnership brings together J&J's anti-Alzheimer's antibodies and the university's adeno-associated viruses (AAVs) in a bid to open up a new frontier in the fight against the disease.
Personal care and consumer goods giant, Johnson & Johnson, announced the winners of its Seoul Quickfire Challenge, which was in partnership with Seoul Metropolitan Government, Korea Health Industry Development Institute (KHIDI), Janssen Korea and Johnson & Johnson Medical Korea.
Johnson & Johnson's (NYSE:JNJ) Janssen Biotech inks a global collaboration and license agreement with Genscript Biotech's Legend Biotech to develop, ... Under the terms of the agreement, Janssen will pay $350M upfront plus milestones in exchange for worldwide rights to jointly develop and ...
French authorities fined Johnson & Johnson $29.62 million after it found the company had deliberately slowed market access to generic copies of Durogesic. ... The French Autorite de la Concurrence said J&J's Janssen had "repeatedly intervened" to block the approval processes in France of Durogesic's ...
Johnson & Johnson's Janssen Oncology unit today unveiled a new website that creates big expectations with its very name: Cancer.com. Created by Janssen with the American Cancer Society, Cancer Support Community and CancerCare, the website has been years in the making. Janssen had owned ...
Slicing that risk in half wasn't “something that five years ago you'd expect,” but the result is right in line with what J&J's Janssen unit predicted based on Darzalex's prior performances. “The drug has been really active, and once we started seeing those results in the relapsed setting, we were expecting to ...
In celebration of the 80th Anniversary of the Finnish Baby Box, the Janssen and Johnson & Johnson Innovation teams created the Next-Gen Baby Box QuickFire Challenge to promote innovation in child health, childhood illness and disease detection and healthy parenting. We worked closely with Finnish ...
Janssen Biotech, a unit of New Brunswick-based Johnson & Johnson, has partnered with China-based Legend Biotech USA and Legend Biotech Ireland to collaborate on a new cancer drug, LCAR-B38M, which is meant to be used in conjunction with CAR T cell cancer therapy. CAR T cell therapy is a new, ...
... Cephalon, Johnson & Johnson, Janssen Pharmaceuticals, Endo Health Solutions, Allergan, Actavis, Watson Pharmaceuticals, McKesson, ...
... Cephalon, Inc., Johnson & Johnson, Janssen Pharmaceuticals, Inc., Ortho-McNeil-Janssen Pharmaceuticals, Inc., Janssen Pharmaceutica, ...
TITUSVILLE, N.J, NOVEMBER 21, 2017 - Janssen Therapeutics, Division of Janssen Products, LP (Janssen), today announced that the U.S. ...
... Orally Delivered Antisense Drug to Johnson & Johnson (JNJ) Janssen Unit ... Under its global collaboration agreement with Janssen, Ionis is ...
Johnson & Johnson and unit Janssen Pharmaceuticals Inc. must face a retrial in a young man's suit alleging their anti-psychotic drug Risperdal ...
Zymeworks (NYSE:ZYME) inks an agreement with Johnson & Johnson (NYSE:JNJ) unit Janssen Biotech granting it a global license to ...
Johnson & Johnson (JNJ) is a $376 billion market cap company trading at .... Janssen Pharmaceutical Companies of Johnson & Johnson is ...
... Johnson & Johnson; Janssen Pharmaceuticals; Ortho-McNeil-Janssen Pharmaceuticals and Janssen Pharmaceutica; Endo Health Solutions ...
"I am proud that Johnson & Johnson established the Bridge to ... Students and their parents also went to Janssen Pharmaceuticals for a ...
MILAN, ITALY, OCTOBER 25, 2017 - Janssen Pharmaceutica, NV today announced that the pivotal Phase 3 AMBER study achieved its primary ...
The Food and Drug Administration expanded the label for Janssen Biotech's Stelera product to include its use as a treatment of adolescents ...
The Janssen and Newfoundland and Labrador Health Innovation ... At the Janssen Pharmaceutical Companies of Johnson & Johnson, we are ...
The Janssen and Newfoundland and Labrador Health Innovation ... At the Janssen Pharmaceutical Companies of Johnson & Johnson, we are ...
Alcobra Ltd (NASDAQ:ADHD) Teams Up With Johnson & Johnson ... and Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson ...
While tour parties were navigating the museum's centre-piece of interactive intestinal and reproductive systems, Johnson & Johnson's (J&J) ...
Today we will discuss a set of three articles on Johnson & Johnson (JNJ), ... Janssen, JNJ's R&D arm, is, along with Roche's (OTCQX:RHHBY) ...
Horsham, Pa., October 20, 2017 ― Janssen Biotech, Inc., announced today that the U.S. Food and Drug Administration (FDA) has approved ...


 

news and opinion


 


 


 


 


schema-root.org

   consumer
     subsidiaries
       janssen
         risperdal